Corcept Therapeutics

National Field Training Manager

Remote

Not SpecifiedCompensation
Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, Pharmaceuticals, HealthcareIndustries

National Field Training Manager

Position Overview

Corcept is a leader in the research and development of cortisol modulators, molecules that regulate cortisol activity at the glucocorticoid receptor (GR). With over 1,000 proprietary cortisol modulators discovered and FDA approval of Korlym® (mifepristone) for hypercortisolism (Cushing’s syndrome), Corcept is dedicated to advancing the possibilities of cortisol modulation for treating serious diseases. The National Field Training Manager will be responsible for providing initial disease state and product training for newly hired Clinical Specialists (CSs) and ongoing field training for the Salesforce. This role involves observing CS activities, deploying training curriculum for new materials and product updates, and assisting in the development and implementation of training initiatives for the Commercial organization.

Employment Type

  • Full-time

Salary

  • $165,000 - $180,000 (The actual pay may vary based on factors such as geographic location, job-related knowledge, skills, experience, and education.)

Location Type

  • Remote (Implied by #LI-Remote)

Responsibilities

  • Conduct regular field rides to ensure appropriate and effective execution and pull-through of training, marketing, and sales initiatives.
  • Aid the Director, Learning & Development, in developing overall product training frameworks, programs, content, collateral, and rollout plans to enhance sales force skills and knowledge, aiming to positively impact sales results.
  • Assist in the execution of all Commercial training programs, including new-hire onboarding, product training, industry updates, competitive landscape reviews, and sales skill development.
  • Facilitate workshops and training classes on various subjects relevant to the sales force.
  • Partner with Sales Management and Regional Training Liaisons (RTLs) to identify training gaps and provide one-on-one field coaching to Clinical Specialists.
  • Assist in the planning and execution of National Field Meetings to align the Field Salesforce with current customer perspectives and Marketing brand goals.
  • Facilitate ongoing distance learning programs to improve field competencies while minimizing time away from customers.
  • Maintain a high level of business intelligence, staying current with new training methods, programs, and best practices.
  • Comply with all laws, regulations, and policies governing Corcept activities.
  • Travel: 50% travel required.

Preferred Skills, Qualifications, and Technical Proficiencies

  • Proven track record of field sales success.
  • Excellent presentation and facilitation skills.
  • Experience coaching and training field-based sales representatives is desired.
  • Strong organizational skills with the ability to manage multiple projects simultaneously and prioritize travel requirements.

Preferred Education and Experience

  • Bachelor's degree.
  • 5+ years of sales experience.
  • 1+ years of field training experience.

Application Instructions

  • Applicants must be currently authorized to work in the United States on a full-time basis.

Company Information

Corcept is leading the way in the research and development of cortisol modulators, molecules that regulate cortisol activity at the glucocorticoid receptor (GR). Corcept has discovered more than 1,000 selective proprietary cortisol modulators and received FDA approval of Korlym® (mifepristone) in 2012, the first approved treatment for hypercortisolism (Cushing’s syndrome). The company's team and collaborators continue to unlock the possibilities of cortisol modulation as a way to treat serious diseases, with more than 30 ongoing studies across a wide range of disease areas including endocrinology, oncology, metabolism, and neurology. Corcept is dedicated to advancing the possibilities of cortisol modulation, representing a fundamental shift in the understanding and treatment of disease.

  • For information on how Corcept collects, uses, discloses, protects, and otherwise processes personal information, please refer to the company's privacy policy.

Skills

Training curriculum development
Salesforce training
Field training
Product training
Clinical education
Sales initiatives
Learning & Development
Training program development
Content development
Rollout plans
Sales results analysis
Commercial organization training

Corcept Therapeutics

Develops cortisol modulators for medical conditions

About Corcept Therapeutics

Corcept Therapeutics focuses on developing treatments that regulate cortisol levels in the body, which is important for managing various health issues. Their main product, Korlym, is used to treat Cushing's syndrome, a condition caused by too much cortisol. Korlym was approved by the FDA in 2012 and is the first medication specifically for this disorder. Corcept stands out from competitors by having a strong emphasis on research and development, having discovered over 1,000 unique cortisol modulators. The company aims to expand its range of treatments while also providing educational resources to healthcare professionals and patients to improve understanding and care for cortisol-related conditions.

Menlo Park, CaliforniaHeadquarters
1998Year Founded
$39.7MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
201-500Employees

Benefits

Remote Work Options
Flexible Work Hours

Risks

Teva's antitrust lawsuit could lead to legal expenses and market share loss.
Heavy reliance on Korlym makes Corcept vulnerable to market fluctuations.
Recent investments may pressure Corcept for short-term financial performance, impacting R&D.

Differentiation

Corcept specializes in cortisol modulation, a niche with few direct competitors.
Korlym is the first FDA-approved treatment for Cushing's syndrome, a significant market advantage.
Corcept's extensive R&D has led to the discovery of over 1,000 selective cortisol modulators.

Upsides

Increased interest in cortisol therapies for mental health boosts Corcept's R&D prospects.
Advancements in drug delivery systems could enhance Corcept's product efficacy.
The FDA's fast-track designation supports Corcept's innovative cortisol-related treatments.

Land your dream remote job 3x faster with AI